ArticleInfection2025

In vivo divergent evolution of cross-resistance to new β-lactam/β-lactamase inhibitor combinations in Pseudomonas aeruginosa following ceftazidime/avibactam treatment.

Heng Cai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.